What Is The Leading Driver Behind Gastrointestinal Disease Prevalence Propels Growth In The Gastric Cancer Diagnostic Procedure Market Market Expansion in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Gastric Cancer Diagnostic Procedure Industry Market Size Be by 2025?
The market valuation for gastric cancer diagnostic procedures has demonstrated robust expansion lately, projected to ascend from $1.44 billion in the year 2024 to $1.54 billion by 2025, reflecting a cumulative annual growth rate (CAGR) of 7.1%. This notable expansion throughout the retrospective period is largely traceable to advancements in techniques employed for biopsies, greater investment in research endeavors, progress in identifying relevant biomarkers, refinements in the methods of pathological assessment, and alterations in established screening protocols.

What's the Long-Term Growth Forecast for the Gastric Cancer Diagnostic Procedure Market Size Through 2029?
The market for diagnosing gastric cancer is anticipated to experience robust expansion over the approaching years, reaching a valuation of $2.06 billion by the year 2029, propelled by a compound annual growth rate (CAGR) of 7.5%; this upswing during the projection timeframe is fundamentally linked to the increasing use of testing at the point of care, the arrival of newly discovered biomarkers, the gradual movement toward individualized patient treatments, greater utilization of next-generation sequencing technologies, and enhancements in methods for endoscopic visualization.

View the full report here:
https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-procedure-global-market-report

What Are the Key Growth Drivers Fueling the Gastric Cancer Diagnostic Procedure Market Expansion?
The mounting occurrence of ailments affecting the digestive tract is presently stimulating the expansion within the market for gastric cancer diagnostic procedures. These gastrointestinal disorders encompass maladies impacting various segments of the alimentary canal along with associated organs like the liver and pancreas. Diagnostic procedures employed for gastric cancer, such as endoscopy and biopsy techniques, are utilized in managing stomach cancer. Consequently, the heightened incidence rate of gastrointestinal diseases serves as a catalyst for the progression of the market dedicated to diagnosing gastric cancer. To illustrate this trend, data released in August 2022 by GI Associates & Endoscopy Center, a United States medical provider focusing on gastroenterology, revealed findings from a multicountry investigation of 73,076 individuals across 33 countries, noting that 40 percent of the participants experienced a functional gastrointestinal disorder. Thus, the widespread nature of gastrointestinal diseases directly underpins the upward trajectory seen in the gastric cancer diagnostic procedure market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12038&type=smp

What Are the Key Trends Driving Gastric Cancer Diagnostic Procedure Market Growth?
A significant upward trend within the gastric cancer diagnostic sector is centered around the uptake of modern technological innovations, compelling key industry participants to integrate novel technologies to maintain competitive footing. As an illustration of this, in the month of June 2022, the Israeli firm Ibex Medical Analytics, which specializes in AI diagnostics for healthcare entities, debuted Galen Gastric, recognized as the inaugural artificial intelligence based solution specifically designed for identifying gastric cancer. This diagnostic instrument functions as a comprehensive tool, assisting pathologists with the detection of stomach cancer, the presence of H. pylori, and various other critical clinical indicators, concurrently enabling faster processing periods and more efficient diagnostic operational procedures.

How Is the Gastric Cancer Diagnostic Procedure Market Segmented?
The gastric cancer diagnostic proceduremarket covered in this report is segmented -

1) By Procedure Type: Endoscopic Procedure; Biopsy; Tissue Tests; Lab Tests; In-Vitro Diagnostic Tests; Imaging Tests; Molecular Diagnostics; Multiplexing Molecular Diagnostics; Immunoassays; Other Procedure Types
2) By Symptom Type: Symptomatic; Asymptomatic
3) By Offering Type: Instruments; Reagents And Consumables; Services
4) By Body Fluid Type: Blood; Urine; Saliva; Stomach Juice; Tissue; Other Body Fluid
5) By Disease Indication: Early Gastric Cancer; Advanced Gastric Cancer

Subsegments:
1) By Endoscopic Procedure: Upper Endoscopy (EGD); Endoscopic Ultrasound (EUS)
2) By Biopsy: Endoscopic Biopsy; Fine Needle Aspiration (FNA) Biopsy
3) By Tissue Tests: Histopathology; Immunohistochemistry
4) By Lab Tests: Blood Tests; Tumor Markers
5) By In-Vitro Diagnostic Tests: Genetic Testing; Molecular Profiling
6) By Imaging Tests: Computed Tomography (CT) Scan; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scan
7) By Molecular Diagnostics: PCR Testing; Next-Generation Sequencing (NGS)
8) By Multiplexing Molecular Diagnostics: Multiplex PCR; Microarray Analysis
9) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA)
10) By Other Procedure Types: Breath Tests; Liquid Biopsies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12038&type=smp

Which Companies Are Leading the Charge in Gastric Cancer Diagnostic Procedure Market Innovation?
Major companies operating in the gastric cancer diagnostic procedure market include Pfizer Inc., Johnson & Johnson Co, F. Hoffmann La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories Inc., Sanofi SA, Eli Lilly and Company, Otsuka Pharmaceutical Co Ltd., AdventHealth, Atrium Health, Astellas Pharma Inc, Bausch Health Companies Inc., Agilent Technologies Inc., Ipsen Pharma, Hartford HealthCare, Myriad Genetics Inc., NovoCure Limited, Foundation Medicine Inc., Biocept Inc.

Which Regions Are Leading the Global Gastric Cancer Diagnostic Procedure Market in Revenue?
North America was the largest region in the gastric cancer diagnostics procedure market in 2024. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12038

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.